• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PGAM5缺失下调FABP1并减弱肝细胞癌中长链脂肪酸摄取

Deletion of PGAM5 Downregulates FABP1 and Attenuates Long-Chain Fatty Acid Uptake in Hepatocellular Carcinoma.

作者信息

Muthusamy Ganesan, Liu Chin-Chi, Johnston Andrea N

机构信息

Louisiana State University School of Veterinary Medicine, Baton Rouge, LA 70803, USA.

出版信息

Cancers (Basel). 2023 Sep 29;15(19):4796. doi: 10.3390/cancers15194796.

DOI:10.3390/cancers15194796
PMID:37835490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10571733/
Abstract

Phosphoglycerate mutase 5 (PGAM5) is a Ser/His/Thr phosphatase responsible for regulating mitochondrial homeostasis. Overexpression of PGAM5 is correlated with a poor prognosis in hepatocellular carcinoma, colon cancer, and melanoma. In hepatocellular carcinoma, silencing of PGAM5 reduces growth, which has been attributed to decreased mitophagy and enhanced apoptosis. Yet in colon cancer, PGAM5's pro-tumor survival effect is correlated to lipid metabolism. We sought to identify whether deletion of PGAM5 modulated lipid droplet accrual in hepatocellular carcinoma. HepG2 and Huh7 knockout cell lines generated using CRISPR/Cas9 technology were used to measure cell growth, cellular ATP, and long-chain fatty acid uptake. Expression of hepatocellular fatty acid transporters, cluster of differentiation 36 (CD36), solute carrier family 27 member 2 (SLC27A2), solute carrier family 27 member 5 (SLC27A5), and fatty acid binding protein 1 (FABP1) was measured by quantitative PCR and Western blot. We found that deletion of PGAM5 attenuates hepatocellular carcinoma cell growth and ATP production. Further, knockout ameliorates palmitate-induced steatosis and reduces expression of FABP1 in HepG2 and Huh7 cell lines. PGAM5's role in hepatocellular carcinoma includes regulation of fatty acid metabolism, which may be related to expression of the fatty acid transporter, FABP1.

摘要

磷酸甘油酸变位酶5(PGAM5)是一种丝氨酸/组氨酸/苏氨酸磷酸酶,负责调节线粒体稳态。PGAM5的过表达与肝细胞癌、结肠癌和黑色素瘤的不良预后相关。在肝细胞癌中,PGAM5的沉默会降低肿瘤生长,这归因于线粒体自噬减少和细胞凋亡增强。然而在结肠癌中,PGAM5的促肿瘤生存作用与脂质代谢相关。我们试图确定PGAM5的缺失是否会调节肝细胞癌中的脂滴积累。使用CRISPR/Cas9技术生成的HepG2和Huh7基因敲除细胞系用于测量细胞生长、细胞ATP和长链脂肪酸摄取。通过定量PCR和蛋白质免疫印迹法检测肝细胞脂肪酸转运蛋白、分化簇36(CD36)、溶质载体家族27成员2(SLC27A2)、溶质载体家族27成员5(SLC27A5)和脂肪酸结合蛋白1(FABP1)的表达。我们发现PGAM5的缺失会减弱肝癌细胞的生长和ATP生成。此外,基因敲除改善了棕榈酸诱导的脂肪变性,并降低了HepG2和Huh7细胞系中FABP1的表达。PGAM5在肝细胞癌中的作用包括调节脂肪酸代谢,这可能与脂肪酸转运蛋白FABP1的表达有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9774/10571733/55522844257b/cancers-15-04796-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9774/10571733/53833fa5e8b6/cancers-15-04796-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9774/10571733/e87cb3ee33ad/cancers-15-04796-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9774/10571733/42df32f088e1/cancers-15-04796-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9774/10571733/08a9f7057c56/cancers-15-04796-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9774/10571733/55522844257b/cancers-15-04796-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9774/10571733/53833fa5e8b6/cancers-15-04796-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9774/10571733/e87cb3ee33ad/cancers-15-04796-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9774/10571733/42df32f088e1/cancers-15-04796-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9774/10571733/08a9f7057c56/cancers-15-04796-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9774/10571733/55522844257b/cancers-15-04796-g005.jpg

相似文献

1
Deletion of PGAM5 Downregulates FABP1 and Attenuates Long-Chain Fatty Acid Uptake in Hepatocellular Carcinoma.PGAM5缺失下调FABP1并减弱肝细胞癌中长链脂肪酸摄取
Cancers (Basel). 2023 Sep 29;15(19):4796. doi: 10.3390/cancers15194796.
2
Phosphoglycerate mutase 5 aggravates alcoholic liver disease through disrupting VDAC-1-dependent mitochondrial integrity.磷酸甘油酸变位酶5通过破坏依赖电压依赖性阴离子通道1的线粒体完整性加重酒精性肝病。
Int J Med Sci. 2024 Feb 25;21(4):755-764. doi: 10.7150/ijms.93171. eCollection 2024.
3
High PGAM5 expression induces chemoresistance by enhancing Bcl-xL-mediated anti-apoptotic signaling and predicts poor prognosis in hepatocellular carcinoma patients.高 PGAM5 表达通过增强 Bcl-xL 介导的抗凋亡信号诱导化疗耐药,并预测肝癌患者预后不良。
Cell Death Dis. 2018 Sep 24;9(10):991. doi: 10.1038/s41419-018-1017-8.
4
Mitochondrion-Localized SND1 Promotes Mitophagy and Liver Cancer Progression Through PGAM5.线粒体定位的SND1通过PGAM5促进线粒体自噬和肝癌进展。
Front Oncol. 2022 Mar 31;12:857968. doi: 10.3389/fonc.2022.857968. eCollection 2022.
5
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.肝细胞癌的代谢失调与新兴治疗靶点
Acta Pharm Sin B. 2022 Feb;12(2):558-580. doi: 10.1016/j.apsb.2021.09.019. Epub 2021 Sep 25.
6
Clinical and prognostic significance of expression of phosphoglycerate mutase family member 5 and Parkin in advanced colorectal cancer.磷酸甘油酸变位酶家族成员5和帕金蛋白在晚期结直肠癌中的表达及其临床和预后意义
World J Clin Cases. 2022 May 16;10(14):4368-4379. doi: 10.12998/wjcc.v10.i14.4368.
7
Phosphoglycerate mutase 5 exacerbates cardiac ischemia-reperfusion injury through disrupting mitochondrial quality control.磷酸甘油酸变位酶 5 通过破坏线粒体质量控制加剧心脏缺血再灌注损伤。
Redox Biol. 2021 Jan;38:101777. doi: 10.1016/j.redox.2020.101777. Epub 2020 Nov 1.
8
Differential effects of PGAM5 knockout on high fat high fructose diet and methionine choline-deficient diet induced non-alcoholic steatohepatitis (NASH) in mice.PGAM5基因敲除对高脂高果糖饮食和蛋氨酸胆碱缺乏饮食诱导的小鼠非酒精性脂肪性肝炎(NASH)的不同影响。
Cell Biosci. 2023 Aug 21;13(1):154. doi: 10.1186/s13578-023-01095-3.
9
A conserved motif mediates both multimer formation and allosteric activation of phosphoglycerate mutase 5.一个保守基序介导磷酸甘油酸变位酶 5 的多聚体形成和别构激活。
J Biol Chem. 2014 Sep 5;289(36):25137-48. doi: 10.1074/jbc.M114.565549. Epub 2014 Jul 10.
10
PGAM5: A crucial role in mitochondrial dynamics and programmed cell death.PGAM5:在线粒体动力学和细胞程序性死亡中的关键作用。
Eur J Cell Biol. 2021 Jan;100(1):151144. doi: 10.1016/j.ejcb.2020.151144. Epub 2020 Dec 7.

引用本文的文献

1
Phosphoglycerate Mutase 5 Is Important Mediator for Instigating Arterial Lipid Accumulation and Aggravating Atherosclerosis.磷酸甘油酸变位酶5是引发动脉脂质积累和加重动脉粥样硬化的重要介质。
JACC Basic Transl Sci. 2025 May;10(5):652-673. doi: 10.1016/j.jacbts.2024.12.007. Epub 2025 Mar 12.
2
LFHP-1c Attenuates Hepatocellular Carcinoma Viability In Vitro Independent of PGAM5.LFHP-1c在体外可降低肝癌细胞活力,与PGAM5无关。
Cancers (Basel). 2025 May 6;17(9):1573. doi: 10.3390/cancers17091573.
3
Physiological and pathological roles of PGAM5: An update and future trend.

本文引用的文献

1
PGAM5 promotes tumorigenesis of gastric cancer cells through PI3K/AKT pathway.PGAM5通过PI3K/AKT信号通路促进胃癌细胞的肿瘤发生。
Pathol Res Pract. 2023 Apr;244:154405. doi: 10.1016/j.prp.2023.154405. Epub 2023 Mar 5.
2
PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression.PGAM5:一种与肿瘤预后不良相关的坏死性凋亡基因,可促进皮肤黑色素瘤进展。
Front Oncol. 2022 Nov 29;12:1004511. doi: 10.3389/fonc.2022.1004511. eCollection 2022.
3
A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma.
PGAM5的生理和病理作用:最新进展与未来趋势
iScience. 2024 Dec 5;28(2):111539. doi: 10.1016/j.isci.2024.111539. eCollection 2025 Feb 21.
4
The potential value of fatty acid binding protein 1 in Chronic HBV-related liver disease progression assessment.脂肪酸结合蛋白 1 在慢性乙型肝炎相关肝病进展评估中的潜在价值。
BMC Infect Dis. 2024 Oct 28;24(1):1214. doi: 10.1186/s12879-024-10114-8.
5
Histidine Phosphorylation: Protein Kinases and Phosphatases.组氨酸磷酸化:蛋白激酶和磷酸酶。
Int J Mol Sci. 2024 Jul 21;25(14):7975. doi: 10.3390/ijms25147975.
一种与线粒体自噬相关的基因特征,用于鉴定肝细胞癌的亚型并预测其预后。
Int J Mol Sci. 2022 Oct 12;23(20):12123. doi: 10.3390/ijms232012123.
4
[Research progress of phosphoglycerate mutase 5-mediated mitophagy and necroptosis].磷酸甘油酸变位酶5介导的线粒体自噬和坏死性凋亡的研究进展
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Aug;34(8):890-896. doi: 10.3760/cma.j.cn121430-20220428-00431.
5
FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors.FABP1 在人类肿瘤中的表达:对 17071 个肿瘤的组织微阵列研究。
Virchows Arch. 2022 Dec;481(6):945-961. doi: 10.1007/s00428-022-03394-5. Epub 2022 Aug 11.
6
Mitochondrion-Localized SND1 Promotes Mitophagy and Liver Cancer Progression Through PGAM5.线粒体定位的SND1通过PGAM5促进线粒体自噬和肝癌进展。
Front Oncol. 2022 Mar 31;12:857968. doi: 10.3389/fonc.2022.857968. eCollection 2022.
7
Lipid metabolism in cancer: A systematic review.癌症中的脂质代谢:一项系统综述。
J Carcinog. 2021 May 6;20:4. doi: 10.4103/jcar.JCar_15_20. eCollection 2021.
8
Mitochondrial Mechanisms of Necroptosis in Liver Diseases.线粒体在肝脏疾病中坏死性凋亡的机制。
Int J Mol Sci. 2020 Dec 23;22(1):66. doi: 10.3390/ijms22010066.
9
PGAM5: A crucial role in mitochondrial dynamics and programmed cell death.PGAM5:在线粒体动力学和细胞程序性死亡中的关键作用。
Eur J Cell Biol. 2021 Jan;100(1):151144. doi: 10.1016/j.ejcb.2020.151144. Epub 2020 Dec 7.
10
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells.体内 CRISPR/Cas9 靶向融合致癌基因选择性消除癌细胞。
Nat Commun. 2020 Oct 8;11(1):5060. doi: 10.1038/s41467-020-18875-x.